MyCartis ^Company

MyCartis is a privately held immunodiagnostics company, providing next generation solutions to detect and quantify protein biomarker signatures by providing precise and personalized novel clinical information for the benefit of researchers, clinicians and CRO’s. MyCartis’ Evalution® platform with Dynamic Multi-Analyte Technology (DMAT®) inside, provides a unique multiplex biomarker platform in combination with the required sensitivity and dynamic range for the integrated analysis of protein biomarkers. DMAT® utilizes proprietary disk-shaped micro-particles which carry a unique code and can be functionalized with specific proteins, antibodies, nucleic acids or other molecules. Thanks to th